Full-Time
Product Marketing Specialist
f/m/x
Posted on 10/1/2025
Zeiss
1,001-5,000 employees
Manufactures high-precision optical instruments and devices
No salary listed
Günzburg, Germany
In Person
 Growth & Marketing (3) |
|---|
| , , |
- bachelor’s degree in business administration, marketing, communication, digital marketing, product marketing or related fields
- coordinate and support the implementation of the go-to-market strategy for new products (hardware and software) as well as updates and upgrades with the relevant stakeholders from the respective business unit, technical application, new customer segments marketing, sales, service, etc. according to strategic priorities
- support constant communication and drive awareness for all product lines within the responsible business unit based on a yearly communication plan
- collaborate closely with the product and application Marketing teams as well as other members of the marketing organization to drive successful marketing campaigns
- support in rolling-out global product marketing campaigns with a high customer-centric approach and create a toolbox for global ZEISS Sales and Service Centers as well as other sales channels (partners, e-shop, etc.)
- create industry-leading marketing assets and campaigns with strong focus on the company’s strategic customer segments to ensure application-driven communication across all product lines
- upload assets to the central data management system and coordinate the product marketing campaign across the different digital marketing channels
- work closely together with the marketing colleagues, product management, technical application and sales teams globally to develop customer-centric communication assets and market-centric campaigns
- actively support the internal implementation of a customer-centric approach into the marketing organization
- work closely together with the national and international Marketing team to improve and make processes and workflows more efficient
- first experience (a minimum of 1-2 years) in product marketing of technical products preferred with basic experience in designing and implementing product launches and customer-centric marketing campaigns
- experience in successfully introducing new products in global & local B2B markets
- basic experience in using the Adobe Creative Suite and other Marketing tools preferred
- good skills in creating catching content with clear messaging matching the ZEISS brand guidelines
- good organizational skills with ability to handle and prioritize multiple projects
- distinctive hands-on mentality as well as self-confident independent working style
- strong team spirit and open communication capabilities paired with creativity
- business English and German fluently written and spoken
ZEISS is a global leader in optics and optoelectronics, serving medical professionals, industrial manufacturers, consumers, and the semiconductor industry. It designs and sells high-precision optical instruments, medical devices, semiconductor manufacturing equipment, and vision care products such as corrective lenses and eye-health services. Its products rely on advanced optics and imaging technologies to deliver accurate inspection, diagnosis, and manufacturing outcomes across healthcare, industrial quality control, consumer optics, and chip fabrication. What sets ZEISS apart is its breadth and depth: a long-standing scale in multiple markets, integrated solutions across optics, imaging, metrology, and precision engineering, and a commitment to sustainability in electricity use and carbon emissions. The company’s goal is to advance optics and optoelectronics by providing reliable, high-quality tools and services worldwide while operating in a sustainable way.
Company Size
1,001-5,000
Company Stage
Growth Equity (Non-Venture Capital)
Total Funding
$1.1B
Headquarters
Oberkochen, Germany
Founded
2001
Simplify's Take
What believers are saying
- Shop-floor metrology adoption accelerates CMM sales into automotive, aerospace, heavy equipment sectors.
- Cloud-based Collaborative Care extends subscription licensing model to industrial quality networks.
- MICOR 700 ultrasound-free handheld device opens portable metrology market in surgical applications.
What critics are saying
- ASML's EUV lithography monopoly threatens ZEISS semiconductor optics segment revenue sustainability.
- VisioGen AI platform faces FDA liability exposure if AI responses cause patient harm.
- Ransomware attack on ZEISS Health Data Platform halts clinical workflows across customer sites.
What makes Zeiss unique
- ZEISS dominates precision optics across semiconductor, medical, and industrial segments globally.
- ARTEVO 850 microscope offers 60% depth-of-field increase with true 3D visualization capability.
- VisioGen AI platform provides human-verified patient engagement integrated into ophthalmology workflows.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Zeiss who can refer or advise you
Benefits
Health Insurance
401(k) Retirement Plan
Paid Vacation
Performance Bonus
Growth & Insights and Company News
6 month growth
↓ -2%1 year growth
↓ -2%2 year growth
↓ -2%ZEISS has unveiled new digital, AI and surgical innovations for cataract and refractive workflows at the ASCRS conference. The medical technology company is expanding its US cataract portfolio with new irrigation/aspiration handpieces compatible with the DORC EVA NEXUS surgical system, alongside enhanced IOL calculation capabilities for the ZEISS IOLMaster 700. ZEISS also launched VisioGen commercially in the US, a human-verified AI patient engagement platform for ophthalmology practices. The platform integrates with clinic websites to capture patient demand around the clock, with AI-assisted responses reviewed by ZEISS-trained optometrists before delivery. The company showcased ZEISS Collaborative Care, a cloud-based application enabling secure data sharing between eye care professionals, and previewed ZEISS CLINIC 360, pending FDA clearance. ZEISS is celebrating 100 years of US operations this year.
ZEISS Medical Technology has expanded its ophthalmic workflow portfolio in Canada with new diagnostic, visualisation and therapeutic solutions. The company will showcase the innovations at upcoming Canadian ophthalmology conferences in Ottawa and Montréal. Key additions include ICGA for ZEISS CLARUS 700, offering simultaneous FA and ICG capture for clinical assessment, and ZEISS VISULAS green with selective laser trabeculoplasty for retinal photocoagulation. The company has introduced refraction devices ZEISS VISUREF 600 and ZEISS VISUCORE 500 to streamline diagnostic workflows. ZEISS also launched VISULAS yag, a new-generation therapeutic laser for anterior segment photodisruption within cataract workflows. The ZEISS FORUM subscription package, now available in Canada, offers integrated data management with unlimited device licences and lower upfront costs.
ZEISS Medical Technology has launched Collaborative Care, a browser-based application enabling eye care professionals to share data securely, refer patients and coordinate clinical care. Built on the ZEISS Health Data Platform, the solution addresses fragmented data sharing and inefficient referral processes in ophthalmic care. The application offers flexible deployment as either a standalone cloud solution or an integrated extension of ZEISS FORUM. Key features include secure exchange of images and reports, streamlined referral workflows with tracking capabilities, and tools for building professional networks between optometrists and ophthalmologists. ZEISS Collaborative Care was demonstrated at industry events in London and Orlando in February and March 2026. The company generated €2,228 million in revenue in fiscal year 2024/25 with 5,784 employees worldwide.
Custom Surgical, a German ophthalmology company, has raised €3.5 million to advance its platform. The funding will support development of AI-powered features including automated image optimisation and assisted triage processes that help determine case urgency and specialist assignment. The company is already developing its first AI-based triage and screening system. The technology aims to provide initial assessments that guide decisions on how urgently cases need attention and which medical professionals should handle them next.
Mindpeak, an AI-driven pathology startup, raised $15.3 million in a Series A round led by ZEISS Ventures and InnoVentureFund in 2024. The funding will accelerate development and deployment of the company's AI diagnostic tools for cancer pathology. Founded in 2018, Mindpeak's algorithms have supported over 30,000 patient diagnoses across US and European healthcare markets. The technology uses automated histological analyses to help pathologists make faster, more precise clinical decisions. CEO Felix Faber stated the capital would expedite product rollouts and expand capabilities. The company has established strategic partnerships with major players including Roche. Mindpeak operates in the rapidly growing digital pathology market, driven by technological innovation and increasing demand for advanced diagnostic services in an ageing population.